Overview
Dr. Behrends' current work focuses on improving HIV and HCV testing and treatment for people who inject drugs in different settings (e.g., substance use disorder treatment programs, syringe exchange programs, etc) and improving strategies for preventing and reversing opioid overdose fatalities. Dr. Behrends' research areas includes harm reduction services, public health, epidemiology of infectious diseases, health services research, and policy impact in the areas of substance use.
Highlights
- 1Drug and alcohol dependence · 2022
- 2Journal of general internal medicine · 2021
- 3Substance abuse · 2021
Publications
61 publications
Funding
15 grantsView NIH portfolio on RePORTER ↗
Active
5 grants- Sub-PIReversing Overdose Epidemics through Simulation, Collaboration, and Unified Efforts (RESCUE)National Institute on Drug Abuse · 2024–2028 · via University of MinnesotaR33DA062346-02
- Sub-PIUnderstanding the short- and long-term effects of the COVID-19 pandemic on the overdose crisisNational Institute on Drug Abuse · 2023–2028 · via New York UniversityR01DA058991-04
- PIExpansion of Mail-Delivered Harm Reduction Services in the U.S.National Institute on Drug Abuse · 2022–2027R01DA057654-02
- Sub-PIA comparative evaluation of overdose prevention programs in New York City and Rhode IslandNational Institute on Drug Abuse · 2023–2027 · via New York UniversityR01DA058277-04
- Co-ICDC Overdose Data to Action: LocalFund for Public Health in New York, Inc. · 2023–2026ContractSA 241817-01
Completed grants (10)
- Sub-PIAddressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populationsNational Institute on Drug Abuse · 2020–2025 · via Yale UniversityU01DA053039-05
- Co-IDAT-18-06 Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND)National Institute on Drug Abuse · 2019–2025
- Sub-PIPew Charitable Trust Community Opioid Effort and Evaluation ProjectPew Charitable Trusts · 2020–2024 · via The REACH Project, Inc.TRP 201434-03
- Co-IDAT 18-06 Feasibility and Acceptability of HIV, HCV, and Opioid Use Disorder Services in Syringe Service ProgramsNational Institute on Drug Abuse · 2015–2024· 4 renewals
- MPIA Multi-Site Multi-Setting RCT of Integrated HIV Prevention and HCV Care for PWIDNational Institute on Drug Abuse · 2017–2024 · via Columbia UniversityR01DA045713-05
- PIImproving Access to Harm Reduction Services for People who Use Drugs in New York State: Evaluation and Feasibility of Expanding Service Delivery Options for Syringe Services ProgramsNew York State Department of Health · 2022–2023DOH01-T37782GG-3450000
- Co-IA Cluster RCT to Increase HIV Testing in Substance Use Treatment ProgramsNational Institute on Drug Abuse · 2016–2022 · via Columbia UniversityR01DA043130-01
- Co-IEvaluation of Community-based Drug User Health Hubs to Reduce Opioid Overdoses in NY StateCenters for Disease Control and Prevention · 2018–2022 · via Health Research INC (Center for Community Health)5 R01 CE00302202-02
- Co-ILocalized Economic Modeling to Optimize Public Health Strategies for HIV treatment and PreventionNational Institute on Drug Abuse · 2016–2021 · via Simon Fraser UniversityR01DA041747-01
- KPSupervised Injection Facility Feasibility StudyFund for Public Health in New York, Inc. · 2017–2017ContractFPHNY SA
Clinical research
7 studies
Active
4 studies- PIFeasibility of increasing uptake of pre-exposure prophylaxis (PrEP) for underserved people who inject drugs with high risk of HIVWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2026)
- PIEnding HIV: Bringing Integrated Prevention and Treatment Services to People Who Use Drugs Where They LiveYale University · OPEN TO ACCRUAL (as of 2025)
- PIEvaluation of overdose prevention centers in New York CityNYU Langone · OPEN TO ACCRUAL (as of 2024)
- PIUnderstanding the short- and long-term effects of the COVID-19 pandemic on the overdose crisisNYU Langone · OPEN TO ACCRUAL (as of 2024)
Completed & closed trials (3)
- PINCT05286879Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved PopulationsNA · National Institute on Drug Abuse · CLOSED TO ACCRUAL (as of 2026)Opioid Use Disorder; Infectious Disease; Risk Reduction Behavior; Substance Use; Substance Abuse; Stimulant Use Disorder
- PIEvaluating the REACH Medical model of care on improving health outcomes for people who inject drugs in Ithaca, New York.Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)
- PINCT03981445A Multi-site Multi-Setting Randomized Controlled Trial (RCT) of Integrated HIV Prevention and HCV Care for People Who Inject Drugs (PWID)NA · Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2023)HIV Prevention; HCV; Opioid Use; Intravenous Drug Usage
News mentions
1 mentionView all WCM news ↗
- Research Highlights Prevention Efforts in Fentanyl OverdosesJanuary 16, 2025
The overwhelming majority of those in New York City who obtained a naloxone kit to counteract opioid overdose had a high need for the drug, according to a new study by Weill Cornell Medicine investigators and the New York City Department of Health and Mental Hygiene.
Mentoring
1 mentee
- SGSimon GagliardiMD mentee · Class of 2025